Sanara Historical Financial Ratios
| SMTI Stock | USD 36.34 0.22 0.60% |
Sanara Medtech is promptly reporting on over 101 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 5.65, Invested Capital of 0.0, Average Payables of 514.5 K or Stock Based Compensation To Revenue of 0.0503 will help investors to properly organize and evaluate Sanara Medtech financial condition quickly.
Sanara |
About Sanara Financial Ratios Analysis
Sanara MedtechFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Sanara Medtech investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Sanara financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Sanara Medtech history.
Sanara Medtech Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Sanara Medtech stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Sanara Medtech sales, a figure that is much harder to manipulate than other Sanara Medtech multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Sanara Medtech dividend as a percentage of Sanara Medtech stock price. Sanara Medtech dividend yield is a measure of Sanara Medtech stock productivity, which can be interpreted as interest rate earned on an Sanara Medtech investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Effective Tax Rate
Effective Tax Rate is the average rate at which Sanara Medtech pre-tax profits are taxed by the government. The effective tax rate is computed by dividing Sanara Medtech total tax expenses by Sanara Medtech earnings before taxes.Return On Assets
A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.Most ratios from Sanara Medtech's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Sanara Medtech current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.As of now, Sanara Medtech's Book Value Per Share is increasing as compared to previous years. The Sanara Medtech's current Average Payables is estimated to increase to about 514.5 K, while Price To Sales Ratio is projected to decrease to 4.97.
| 2023 | 2024 (projected) | Dividend Yield | 0.0308 | 0.0324 | Price To Sales Ratio | 5.24 | 4.97 |
Sanara Medtech fundamentals Correlations
Click cells to compare fundamentals
Sanara Medtech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sanara Medtech fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 2.92 | 18.36 | 8.99 | 7.85 | 5.24 | 4.97 | |
| Ptb Ratio | 5.19 | 46.52 | 7.08 | 8.6 | 7.59 | 7.97 | |
| Days Sales Outstanding | 41.42 | 53.08 | 45.2 | 55.76 | 47.92 | 79.22 | |
| Book Value Per Share | 3.0 | 1.02 | 4.11 | 5.28 | 5.39 | 5.65 | |
| Free Cash Flow Yield | (0.11) | (0.0198) | (0.0257) | (0.0175) | (0.0103) | (0.0108) | |
| Operating Cash Flow Per Share | 0.13 | (1.02) | (0.7) | (0.66) | (0.39) | (0.41) | |
| Capex To Depreciation | 14.22 | 5.64 | 1.26 | 0.32 | 0.0722 | 0.0686 | |
| Pb Ratio | 5.19 | 46.52 | 7.08 | 8.6 | 7.59 | 7.97 | |
| Ev To Sales | 2.53 | 18.36 | 8.23 | 7.67 | 5.34 | 5.07 | |
| Free Cash Flow Per Share | (1.82) | (0.99) | (0.76) | (0.8) | (0.42) | (0.45) | |
| Roic | (0.33) | (0.79) | (0.22) | (0.17) | (0.0768) | (0.0806) | |
| Inventory Turnover | 1.09 | 1.62 | 1.41 | 1.79 | 1.66 | 2.68 | |
| Net Income Per Share | (1.37) | (0.76) | (1.0) | (1.02) | (0.52) | (0.55) | |
| Days Of Inventory On Hand | 225.32 | 259.25 | 323.46 | 203.65 | 219.28 | 349.66 | |
| Sales General And Administrative To Revenue | 0.98 | 1.11 | 1.2 | 1.16 | 1.15 | 1.75 | |
| Capex To Revenue | 0.14 | 0.11 | 0.0311 | 0.0163 | 0.004081 | 0.003877 | |
| Cash Per Share | 0.34 | 3.1 | 0.0794 | 2.54 | 1.13 | 0.62 | |
| Pocfratio | (15.84) | (70.93) | (45.06) | (64.76) | (104.84) | (110.08) | |
| Interest Coverage | (24.83) | (434.13) | (10.4K) | (42.96) | (8.86) | (9.3) | |
| Capex To Operating Cash Flow | (0.79) | (0.41) | (0.16) | (0.13) | (0.0817) | (0.0858) | |
| Pfcf Ratio | (8.87) | (50.39) | (38.98) | (57.09) | (96.92) | (101.77) | |
| Days Payables Outstanding | 138.78 | 101.87 | 111.72 | 81.87 | 93.05 | 88.4 | |
| Income Quality | 0.76 | 0.91 | 0.6 | 0.69 | 0.75 | 0.79 | |
| Roe | (0.44) | (0.71) | (0.24) | (0.19) | (0.096) | (0.1) | |
| Ev To Operating Cash Flow | (13.76) | (70.93) | (41.27) | (63.3) | (106.89) | (112.23) | |
| Pe Ratio | (11.72) | (65.29) | (29.7) | (44.46) | (79.07) | (83.03) | |
| Return On Tangible Assets | (0.3) | (0.65) | (0.23) | (0.31) | (0.17) | (0.18) | |
| Ev To Free Cash Flow | (7.7) | (50.39) | (35.71) | (55.8) | (98.81) | (103.75) | |
| Earnings Yield | (0.0853) | (0.0153) | (0.0337) | (0.0225) | (0.0126) | (0.0133) | |
| Intangibles To Total Assets | 0.0172 | 0.13 | 0.32 | 0.58 | 0.66 | 0.33 | |
| Net Debt To E B I T D A | 1.73 | (0.006465) | 2.52 | 0.69 | (22.98) | (21.84) | |
| Current Ratio | 3.35 | 1.27 | 4.09 | 1.61 | 1.38 | 0.74 | |
| Tangible Book Value Per Share | 2.31 | 0.48 | 3.46 | 0.84 | (0.48) | (0.5) |
Currently Active Assets on Macroaxis
When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 9.241 | Quarterly Revenue Growth 0.352 | Return On Assets (0.05) | Return On Equity (0.20) |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.